Ellis Investment Partners, LLC Bristol Myers Squibb CO Transaction History

Ellis Investment Partners, LLC

$495 Million
Q4 2024

A detailed history of Ellis Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 5,186 shares of BMY stock, worth $289,534. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,186

Previous 4,338 19.55%

Holding current value

$289,534

Previous $224,000 30.8%

% of portfolio

0.06%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$51.92 - $59.94 $44,028 - $50,829	848 Added 19.55%	5,186 $293,000
Q3 2024 Oct 24, 2024	BUY	$39.66 - $51.75 $172,045 - $224,491	4,338 New	4,338 $224,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $40,543 - $45,968	-845 Reduced 10.81%	6,973 $378,000
Q4 2023 Jan 29, 2024	BUY	$48.48 - $57.85 $6,981 - $8,330	144 Added 1.88%	7,818 $401,000
Q3 2023 Nov 01, 2023	BUY	$57.89 - $64.73 $7,930 - $8,868	137 Added 1.82%	7,674 $445,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $34,913 - $38,765	548 Added 7.84%	7,537 $481,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $11,893 - $13,489	-181 Reduced 2.52%	6,989 $484,000
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $1,780 - $2,108	26 Added 0.36%	7,170 $515,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $66 - $39,188	-510 Reduced 6.66%	7,144 $507,000
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $18,372 - $20,234	-253 Reduced 3.2%	7,654 $589,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $121,054 - $145,154	-1,969 Reduced 19.94%	7,907 $577,000
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $13,192 - $15,379	246 Added 2.55%	9,876 $615,000
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $59 - $69	1 Added 0.01%	9,630 $569,000
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $38,198 - $41,598	617 Added 6.85%	9,629 $643,000
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $2,432 - $2,736	41 Added 0.46%	9,012 $569,000
Q4 2020 Jan 20, 2021	SELL	$57.74 - $65.43 $2,078 - $2,355	-36 Reduced 0.4%	8,971 $556,000
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $574 - $636	-10 Reduced 0.11%	9,007 $543,000
Q2 2020 Jul 13, 2020	BUY	$54.82 - $64.09 $2,083 - $2,435	38 Added 0.42%	9,017 $535,000
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $67,883 - $98,650	-1,463 Reduced 14.01%	8,979 $492,000
Q4 2019 Jan 07, 2020	BUY	$49.21 - $64.19 $29,772 - $38,834	605 Added 6.15%	10,442 $661,000
Q3 2019 Oct 09, 2019	BUY	$42.77 - $50.71 $2,395 - $2,839	56 Added 0.57%	9,837 $498,000
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $71,927 - $79,536	1,612 Added 19.73%	9,781 $451,000
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $17.2 Million - $20.5 Million	-381,616 Reduced 97.9%	8,169 $384,000
Q1 2019 Apr 24, 2019	BUY	$45.12 - $53.8 $17.6 Million - $21 Million	389,785 New	389,785 $389,000
Q1 2019 Apr 22, 2019	SELL	$45.12 - $53.8 $238,098 - $283,902	-5,277 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$48.76 - $63.23 $257,306 - $333,664	5,277 New	5,277 $274,000

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.

Account

Ellis Investment Partners, LLC Bristol Myers Squibb CO Transaction History